Posttranscriptional modulation of cytokine production in T cells for the regulation of excessive inflammation by TFL

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1512-1524

  Minagawa, Kentaro ^a   Wakahashi, Kanako ^a   Kawano, Hiroki ^a   Nishikawa, Shinichiro ^a   Fukui, Chie ^a   Kawano, Yuko ^a   Asada, Noboru ^a   Sato, Mari ^a   Sada, Akiko ^a   Katayama, Yoshio ^a   Matsui, Toshimitsu ^b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nishiwaki Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; RNA; TUMOR NECROSIS FACTOR ALPHA;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RNA DEGRADATION; T LYMPHOCYTE; TFL GENE; TH17 CELL; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOMA, FOLLICULAR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RIBONUCLEASES; RNA PROCESSING, POST-TRANSCRIPTIONAL; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 84896728613     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301619     Document Type: Article

References (61)

1. Eulalio, A., I. Behm-Ansmant, and E. Izaurralde. 2007. P bodies: at the crossroads of post-transcriptional pathways. Nat. Rev. Mol. Cell Biol. 8: 9-22.
2. Anderson, P. 2010. Post-transcriptional regulons coordinate the initiation and resolution of inflammation. Nat. Rev. Immunol. 10: 24-35.
3. Anderson, P. 2008. Post-transcriptional control of cytokine production. Nat. Immunol. 9: 353-359.
4. Moser, J. J., and M. J. Fritzler. 2010. Cytoplasmic ribonucleoprotein (RNP) bodies and their relationship to GW/P bodies. Int. J. Biochem. Cell Biol. 42: 828-843.
5. Carballo, E., W. S. Lai, and P. J. Blackshear. 1998. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281: 1001-1005.
6. Ogilvie, R. L., M. Abelson, H. H. Hau, I. Vlasova, P. J. Blackshear, and P. R. Bohjanen. 2005. Tristetraprolin down-regulates IL-2 gene expression through AU-rich element-mediated mRNA decay. J. Immunol. 174: 953-961.
7. Ogilvie, R. L., J. R. Sternjohn, B. Rattenbacher, I. A. Vlasova, D. A. Williams, H. H. Hau, P. J. Blackshear, and P. R. Bohjanen. 2009. Tristetraprolin mediates interferon-γ mRNA decay. J. Biol. Chem. 284: 11216-11223.
8. Qian, X., H. Ning, J. Zhang, D. F. Hoft, D. J. Stumpo, P. J. Blackshear, and J. Liu. 2011. Posttranscriptional regulation of IL-23 expression by IFN-γ through tristetraprolin. J. Immunol. 186: 6454-6464.
9. Lee, H. H., N. A. Yoon, M. T. Vo, C. W. Kim, J. M. Woo, H. J. Cha, Y. W. Cho, B. J. Lee, W. J. Cho, and J. W. Park. 2012. Tristetraprolin down-regulates IL-17 through mRNA destabilization. FEBS Lett. 586: 41-46.
10. Vinuesa, C. G., M. C. Cook, C. Angelucci, V. Athanasopoulos, L. Rui, K. M. Hill, D. Yu, H. Domaschenz, B. Whittle, T. Lambe, et al. 2005. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435: 452-458.
11. Yu, D., A. H. Tan, X. Hu, V. Athanasopoulos, N. Simpson, D. G. Silva, A. Hutloff, K. M. Giles, P. J. Leedman, K. P. Lam, et al. 2007. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450: 299-303.
12. Vogel, K. U., S. L. Edelmann, K. M. Jeltsch, A. Bertossi, K. Heger, G. A. Heinz, J. Zöller, S. C. Warth, K. P. Hoefig, C. Lohs, et al. 2013. Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity 38: 655-668.
13. Taylor, G. A., E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson, D. D. Patel, D. I. Schenkman, G. S. Gilkeson, H. E. Broxmeyer, B. F. Haynes, and P. J. Blackshear. 1996. A pathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445-454.
14. Baou, M., J. D. Norton, and J. J. Murphy. 2011. AU-rich RNA binding proteins in hematopoiesis and leukemogenesis. Blood 118: 5732-5740.
15. Hodson, D. J., M. L. Janas, A. Galloway, S. E. Bell, S. Andrews, C. M. Li, R. Pannell, C. W. Siebel, H. R. MacDonald, K. De Keersmaecker, et al. 2010. Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia. Nat. Immunol. 11: 717-724.
16. Rounbehler, R. J., M. Fallahi, C. Yang, M. A. Steeves, W. Li, J. R. Doherty, F. X. Schaub, S. Sanduja, D. A. Dixon, P. J. Blackshear, and J. L. Cleveland. 2012. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell 150: 563-574.
17. Minagawa, K., K. Yamamoto, S. Nishikawa, M. Ito, A. Sada, K. Yakushijin, A. Okamura, M. Shimoyama, Y. Katayama, and T. Matsui. 2007. Deregulation of a possible tumour suppressor gene, ZC3H12D, by translocation of IGK@ in transformed follicular lymphoma with t(2;6)(p12;q25). Br. J. Haematol. 139: 161-163.
18. Liang, J., W. Song, G. Tromp, P. E. Kolattukudy, and M. Fu. 2008. Genome-wide survey and expression profiling of CCCH-zinc finger family reveals a functional module in macrophage activation. PLoS ONE 3: e2880.
19. Wang, M., H. G. Vikis, Y. Wang, D. Jia, D. Wang, L. J. Bierut, J. E. Bailey-Wilson, C. I. Amos, S. M. Pinney, G. M. Petersen, et al. 2007. Identification of a novel tumor suppressor gene p34 on human chromosome 6q25.1. Cancer Res. 67: 93-99.
20. Minagawa, K., Y. Katayama, S. Nishikawa, K. Yamamoto, A. Sada, A. Okamura, M. Shimoyama, and T. Matsui. 2009. Inhibition of G1 to S phase progression by a novel zinc finger protein P58(TFL) at P-bodies. Mol. Cancer Res. 7: 880-889.
21. Matsushita, K., O. Takeuchi, D. M. Standley, Y. Kumagai, T. Kawagoe, T. Miyake, T. Satoh, H. Kato, T. Tsujimura, H. Nakamura, and S. Akira. 2009. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458: 1185-1190.
22. Anantharaman, V., and L. Aravind. 2006. The NYN domains: novel predicted RNAses with a PIN domain-like fold. RNA Biol. 3: 18-27.
23. Liang, J., Y. Saad, T. Lei, J. Wang, D. Qi, Q. Yang, P. E. Kolattukudy, and M. Fu. 2010. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling. J. Exp. Med. 207: 2959-2973.
24. Liang, J., J. Wang, A. Azfer, W. Song, G. Tromp, P. E. Kolattukudy, and M. Fu. 2008. A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages. J. Biol. Chem. 283: 6337-6346.
25. Chen, Y. L., Y. L. Huang, N. Y. Lin, H. C. Chen, W. C. Chiu, and C. J. Chang. 2006. Differential regulation of ARE-mediated TNFalpha and IL-1β mRNA stability by lipopolysaccharide in RAW264.7 cells. Biochem. Biophys. Res. Commun. 346: 160-168.
26. Hao, S., and D. Baltimore. 2009. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 10: 281-288.
27. Stoecklin, G., S. A. Tenenbaum, T. Mayo, S. V. Chittur, A. D. George, T. E. Baroni, P. J. Blackshear, and P. Anderson. 2008. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 283: 11689-11699.
28. Nagata, A., M. Ito, N. Iwata, J. Kuno, H. Takano, O. Minowa, K. Chihara, T. Matsui, and T. Noda. 1996. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. USA 93: 11825-11830.
29. Iwata, N., T. Murayama, Y. Matsumori, M. Ito, A. Nagata, T. Taniguchi, K. Chihara, Y. Matsuo, J. Minowada, and T. Matsui. 1996. Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells. Blood 88: 2683-2689.
30. Okamura, A., N. Iwata, A. Nagata, A. Tamekane, M. Shimoyama, H. Gomyo, K. Yakushijin, N. Urahama, M. Hamaguchi, C. Fukui, et al. 2004. Involvement of casein kinase Iε in cytokine-induced granulocytic differentiation. Blood 103: 2997-3004.
31. Huang, S., D. Qi, J. Liang, R. Miao, K. Minagawa, T. Quinn, T. Matsui, D. Fan, J. Liu, and M. Fu. 2012. The putative tumor suppressor Zc3h12d modulates Tolllike receptor signaling in macrophages. Cell. Signal. 24: 569-576.
32. Kawano, H., Y. Katayama, K. Minagawa, M. Shimoyama, M. Henkemeyer, and T. Matsui. 2012. A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition. Eur. J. Immunol. 42: 1562-1572.
33. Kawamori, Y., Y. Katayama, N. Asada, K. Minagawa, M. Sato, A. Okamura, M. Shimoyama, K. Nakagawa, T. Okano, M. Tanimoto, et al. 2010. Role for vitamin D receptor in the neuronal control of the hematopoietic stem cell niche. Blood 116: 5528-5535.
34. + T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27: 2840-2847.
35. Li, M., W. Cao, H. Liu, W. Zhang, X. Liu, Z. Cai, J. Guo, X. Wang, Z. Hui, H. Zhang, et al. 2012. MCPIP1 down-regulates IL-2 expression through an ARE-independent pathway. PLoS ONE 7: e49841.
36. + helper T cells regulates immune activation. Cell 153: 1036-1049.
37. Suzuki, H. I., M. Arase, H. Matsuyama, Y. L. Choi, T. Ueno, H. Mano, K. Sugimoto, and K. Miyazono. 2011. MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol. Cell 44: 424-436.
38. Eulalio, A., I. Behm-Ansmant, D. Schweizer, and E. Izaurralde. 2007. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol. Cell. Biol. 27: 3970-3981.
39. Leppek, K., J. Schott, S. Reitter, F. Poetz, M. C. Hammond, and G. Stoecklin. 2013. Roquin promotes constitutive mRNA decay via a conserved class of stemloop recognition motifs. Cell 153: 869-881.
40. Glasmacher, E., K. P. Hoefig, K. U. Vogel, N. Rath, L. Du, C. Wolf, E. Kremmer, X. Wang, and V. Heissmeyer. 2010. Roquin binds inducible costimulator mRNA and effectors of mRNA decay to induce microRNA-independent post-transcriptional repression. Nat. Immunol. 11: 725-733.
41. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
42. Han, M. H., D. H. Lundgren, S. Jaiswal, M. Chao, K. L. Graham, C. S. Garris, R. C. Axtell, P. P. Ho, C. B. Lock, J. I. Woodard, et al. 2012. Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J. Exp. Med. 209: 1325-1334.
43. Raghavan, A., R. L. Robison, J. McNabb, C. R. Miller, D. A. Williams, and P. R. Bohjanen. 2001. HuA and tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J. Biol. Chem. 276: 47958-47965.
44. Glass, C. K., and S. Ogawa. 2006. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat. Rev. Immunol. 6: 44-55.
45. Natarajan, C., G. Muthian, Y. Barak, R. M. Evans, and J. J. Bright. 2003. Peroxisome proliferator-activated receptor-γ-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis. J. Immunol. 171: 5743-5750.
46. Chen, C. Y., R. Gherzi, J. S. Andersen, G. Gaietta, K. Jürchott, H. D. Royer, M. Mann, and M. Karin. 2000. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 14: 1236-1248.
47. H2 cytokines. Nat. Immunol. 2: 37-44.
48. Stoecklin, G., and P. Anderson. 2006. Posttranscriptional mechanisms regulating the inflammatory response. Adv. Immunol. 89: 1-37.
49. Iwasaki, H., O. Takeuchi, S. Teraguchi, K. Matsushita, T. Uehata, K. Kuniyoshi, T. Satoh, T. Saitoh, M. Matsushita, D. M. Standley, and S. Akira. 2011. The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1. Nat. Immunol. 12: 1167-1175.
50. Marderosian, M., A. Sharma, A. P. Funk, R. Vartanian, J. Masri, O. D. Jo, and J. F. Gera. 2006. Tristetraprolin regulates cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene 25: 6277-6290.
51. Bonnet, M., M. Loosveld, B. Montpellier, J. M. Navarro, B. Quilichini, C. Picard, J. Di Cristofaro, C. Bagnis, C. Fossat, L. Hernandez, et al. 2011. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood 117: 6650-6659.
52. Egle, A., A. W. Harris, M. L. Bath, L. O'Reilly, and S. Cory. 2004. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103: 2276-2283.
53. Kridel, R., L. H. Sehn, and R. D. Gascoyne. 2012. Pathogenesis of follicular lymphoma. J. Clin. Invest. 122: 3424-3431.
54. Pangault, C., P. Amé-Thomas, P. Ruminy, D. Rossille, G. Caron, M. Baia, J. De Vos, M. Roussel, C. Monvoisin, T. Lamy, et al. 2010. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH-B cell axis. Leukemia 24: 2080-2089.
55. Crotty, S. 2011. Follicular helper CD4 T cells (TFH). Annu. Rev. Immunol. 29: 621-663.
56. Miossec, P. 2003. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 48: 594-601.
57. Fitch, E., E. Harper, I. Skorcheva, S. E. Kurtz, and A. Blauvelt. 2007. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr. Rheumatol. Rep. 9: 461-467.
58. Monteleone, G., F. Pallone, and T. T. MacDonald. 2011. Emerging immunological targets in inflammatory bowel disease. Curr. Opin. Pharmacol. 11: 640-645.
59. Shin, M. S., N. Lee, and I. Kang. 2011. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells. Curr. Opin. Rheumatol. 23: 444-448.
60. Nishimori, H., Y. Maeda, T. Teshima, H. Sugiyama, K. Kobayashi, Y. Yamasuji, S. Kadohisa, H. Uryu, K. Takeuchi, T. Tanaka, et al. 2012. Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17. Blood 119: 285-295.
61. Tsoi, L. C., S. L. Spain, J. Knight, E. Ellinghaus, P. E. Stuart, F. Capon, J. Ding, Y. Li, T. Tejasvi, J. E. Gudjonsson, et al Collaborative Association Study of Psoriasis (CASP); Genetic Analysis of Psoriasis Consortium; Psoriasis Association Genetics Extension; Wellcome Trust Case Control Consortium 2. 2012. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44: 1341-1348.